细胞外囊泡和癌症干细胞:在瘤进展中致命的二人组
Akram Tayanloo-Beik1, Azin Eslami1, Masoumeh Sarvari2
1Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Oncology reviews
|August 2, 2024
概括
癌症干细胞 (CSC) 和细胞外囊泡 (EV) 驱动癌症的进展和治疗耐药性. 了解它们的相互作用是开发新型癌症治疗和改善患者治疗结果的关键.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 全球癌症发病率正在上升,预计到2030年,每年新增2600万例,死亡1700万例.
- 癌症干细胞 (CSCs) 对于瘤的发病,进展和复发至关重要,原因是药物耐药性和自我更新.
- 细胞外囊泡 (EVs) 在瘤微环境中调解细胞间通信,影响细胞行为和遗传改变.
研究的目的:
- 分析CSC和EV之间的共生关系.
- 阐明它们在促进瘤转移和治疗耐药性的联合作用.
- 确定CSC和EV作为新型癌症治疗的潜在治疗点.
主要方法:
- 文献审查和对CSC和EV现有研究的分析.
- 检查CSC-EV相互作用背后的分子机制.
- 综合当前对它们在癌症进展中的作用的理解.
主要成果:
- CSCs和EVs形成一个互利的协会,促进瘤生长和扩散.
- 这种相互作用对抗各种癌症疗法的耐药性发展作出了重大贡献.
- 电动汽车促进了增强CSC属性的通信,包括自我更新和生存.
结论:
- 针对CSC和EV之间的相互作用,为克服癌症治疗耐药性提供了一个有希望的策略.
- 对CSC-EV动态的进一步研究可以导致创新的治疗方法.
- 了解这些相互作用为减少全球癌症负担提供了新的乐观情绪.
更多相关视频
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


